top of page

Free Biopharma Daily Stock Updates - 07/23/21

  • Writer: BPIQ
    BPIQ
  • Jul 23, 2021
  • 1 min read

$XBI $126 -1%

Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30 days free, no credit card required. Check it out here!

Covid Updates

$CRTX -1% Cortexyme Announces Lead 3CLpro Inhibitor for the Treatment of Coronavirus Infection. source


Pipeline Updates

$TNXP -35% Tonix Pharmaceuticals Announces Outcome of Interim Analysis of Phase 3 RALLY Study of TNX-102 SL for the Management of Fibromyalgia. source


$SRNE -6% Lee’s Pharmaceutical Announces First Patient Dosed With its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, as a First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer. source


$RDUS -2% CORRECTION: Radius Health Announces Plans for Global Prader-Willi Syndrome Pivotal Study. source


$OCUL +2% OCULAR THERAPEUTIX™ TO PRESENT CLINICAL DATA AT THE 2021 AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY (ASCRS) ANNUAL MEETING. source


$ABEO -4% Abeona Therapeutics Activates Second Clinical Trial Site in EB-101 Pivotal Phase 3 VIITAL™ Study for Recessive Dystrophic Epidermolysis Bullosa. source


Financial Updates

$CYTK -1% Closed public offering.

Posted by DV

 
 
 

Comments

bottom of page